RSK inhibitor BI-D1870 inhibits acute myeloid leukemia cell proliferation by targeting mitotic exit

The 90 kDa Ribosomal S6 Kinase (RSK) drives cell proliferation and survival in cancers, although its oncogenic mechanism has not been well characterized. Phosphorylated level of RSK (T573) was increased in acute myeloid leukemia (AML) patients and associated with poor survival. To examine the role o...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Oncotarget
Asıl Yazarlar: Chae, Hee-Don, Dutta, Ritika, Tiu, Bruce, Hoff, Fieke W., Accordi, Benedetta, Serafin, Valentina, Youn, Minyoung, Huang, Min, Sumarsono, Nathan, Davis, Kara L., Lacayo, Norman J., Pigazzi, Martina, Horton, Terzah M., Kornblau, Steven M., Sakamoto, Kathleen M.
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Impact Journals LLC 2020
Konular:
Research Paper
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC7321696/
https://ncbi.nlm.nih.gov/pubmed/32637030
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.18632/oncotarget.27630
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller